Trends In Cancer Screening Among People Living with HIV In Ontario, 2017 To 2023: A Population-Based Analysis

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 521484

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2025
  • Known Financial Commitments (USD)

    $1,912.57
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Saeedeh Moayedi Nia
  • Research Location

    Canada
  • Lead Research Institution

    Unity Health Toronto
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures
  • Research Subcategory

    Indirect health impacts
  • Special Interest Tags

    N/A
  • Study Type

    Clinical
  • Clinical Trial Details

    Not applicable
  • Broad Policy Alignment

    Pending
  • Age Group

    Adults (18 and older)
  • Vulnerable Population

    Other
  • Occupations of Interest

    Unspecified

Abstract

Background People living with HIV (PLWH) face a higher risk of certain cancers, making timely screening essential. This study examined cancer screening trends among individuals living with and without HIV in Ontario. Methods We conducted a retrospective longitudinal study using linked health administrative data from April 2017 to October 2023. Screening outcomes included the biannual proportion of eligible adults up to date with colorectal (fecal test in the previous two years or a flexible sigmoidoscopy or colonoscopy in the previous ten years), breast (mammogram in the previous two years), and cervical (Papanicolaou test in the previous three years) screenings. Results PLWH were more likely to live in low-income neighborhoods, urban areas, and to be immigrants, with a high burden of comorbidities. Among females, those living with HIV had consistently lower rates of up-to-date breast and colorectal cancer screenings compared to females living without HIV. In contrast, males living with HIV had higher rates of colorectal cancer screening. During the COVID-19 pandemic, screening rates dropped sharply, particularly for breast cancer screening (April 2019 vs. April 2021: declines of 12.6% for females living without HIV and 9.6% for females living with HIV). While some recovery was observed post-lockdowns, cervical screening rates remained below pre-pandemic levels. Conclusions This study reveals ongoing disparities in breast and colorectal cancer screening for females living with HIV and highlights the pandemic's impact on preventive care. Addressing barriers to cancer screening is crucial to improving health outcomes for PLWH.